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a b s t r a c t 
Here, we present the data on the biological effects of Hyptis 
spp. and Lycium spp. plant extracts in Caenorhabditis elegans 
( C. elegans ) models of neurodegenerative diseases, which is 
related to the work presented in the article “Neurotherapeu- 
tic effect of Hyptis spp. leaf extracts in C. elegans models of 
tauopathy and polyglutamine disease: role of the glutathione 
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redox cycle” [1] . This dataset was generated to define non- 
toxic concentrations of these plant extracts and to as- 
sess their impact on the motor phenotype and oxidative 
stress resistance of transgenic C. elegans models of two 
genetically defined neurodegenerative diseases: Machado- 
Joseph disease and Frontotemporal dementia with Parkin- 
sonism associated to the chromosome 17. The impact of 
the plant extracts on toxicity was assessed using the food- 
clearance assay, absorbance being measured daily for seven 
days at 595 nm to quantify Escherichia coli ( E. coli ) strain 
OP50 bacteria consumption. Worm length and motor be- 
haviour, including spontaneous and stimulated movement, 
were analysed using videos acquired with an Olympus 
SZX7 stereomicroscope with an integrated camera (Olym- 
pus SC30) and processed using the Image J® software and 
the Wrmtrck plugin. The resistance to oxidative stress in- 
duced by 240 μM juglone was assessed by determining 
the percentage of live animals after 1 hour of exposure. 
© 2020 Published by Elsevier Inc. 
This is an open access article under the CC BY-NC-ND 
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Specifications Table 
Subject Molecular Medicine 
Specific subject area Drug discovery/chemical biology 
Type of data Table 
Image 
Figure 
How data were acquired Toxicity data were acquired through the daily measure of absorbance at 595 nm in 
the plate reader NanoQuant Plate TM (Tecan) 
To evaluate the impact of plant extracts treatment on the motor phenotype of the 
C. elegans models of neurodegenerative diseases, videos of treated animals were 
acquired using an Olympus SZX7 stereomicroscope with an integrated camera 
(Olympus SC30) and processed using the Image J® software [2] and the Wrmtrck 
plugin [3] . 
Data on oxidative stress resistance were obtained by the scoring of survival of 
adult animals (in an Olympus SZX7 stereomicroscope), chronically treated with 
extracts and submitted to an oxidative insult caused by juglone. 
Data format Raw 
Analyzed 
Parameters for data collection Methanolic extracts of: leafs of Hyptis suaveolens, Hyptis pectinata, Hyptis 
marrubioides ; and fruits of Lycium barbarum and Lycium ruthenicum, were used to 
chronically treat wild-type and C. elegans transgenic models of neurodegenerative 
diseases: Frontotemporal dementia with parkinsonism linked to chromosome 17 
(human mutant tau V337M) [4] and Machado-Joseph disease (human mutant 
ATXN3 with 130 polyglutamines) [5] , until day 4 after hatching. C. elegans models 
of neurodegenerative diseases, chronically treated with the plant extracts were 
also exposured to juglone for 1 hour. 
Description of data collection Toxicity data were estimated in wild-type treated animals through the estimation 
of bacteria ( E. coli strain OP50) consumption, for 7 days, measured at 595 nm 
(NanoQuant Plate TM -Tecan). 
The effect of the chronic treatment with plant extracts in disease models was 
evaluated through the estimation of animals’ mean velocity. For this, populations 
of adult treated animals were recorded for 60 seconds while moving spontaneously 
and 30 seconds after being stimulated by a mechanic stimulus (plate tap). 
Oxidative stress resistance was evaluated submitting the C. elegans disease models, 
chronically treated with the plant extracts, to 240 μM of juglone for 1 hour. After 
16 hours of recovery, dead/alive animals were counted. 




















( continued on next page ) 
Data source location University of Minho, Braga 
Portugal 
Data accessibility With the article. 
The raw data is in the Mendeley Data repository, with the following link: 
http://dx.doi.org/10.17632/8v27k37dg2.1 . 
The detailed data and statistical analysis are in supplementary data in appendix A. 
Related research article D. Vilasboas-Campos, M.D. Costa, A. Teixeira-Castro, R. Rios, F.G. Silva, C. Bessa, 
A.C.P. Dias, P. Maciel, Neurotherapeutic effect of Hyptis spp. leaf extracts in 
Caenorhabditis elegans models of tauopathy and polyglutamine disease: role of the 
glutathione redox cycle, Free Radic. Biol. Med. (2020). 
https://doi.org/10.1016/j.freeradbiomed.2020.10.018 . 
Value of the Data 
• These data provide new information about the impact of distinct plant extracts on nematode
models of neurodegenerative diseases, clarifying their potential use as sources of therapeutic
compounds for such incurable disorders. 
• Identification of bioactivities of natural compounds can be relevant for the discovery of new
therapeutic agents to benefit patients with neurodegenerative diseases. 
• This data can guide future research on these or other plant extracts or on their bioactive iso-
lated compounds, towards the identification of new therapeutic agents for human diseases. 
1. Data Description 
The dataset of this study was used to investigate the toxicity of distinct plant extracts in vivo
as well as their effects on motor function and oxidative stress resistance of C. elegans models
of neurodegenerative diseases (Tauopathies and Machado-Joseph disease) as exemplified in the
experimental workflow shown in Experimental design, Materials and Methods section. 
1.1. Non-toxic concentrations 
In order to define the concentrations of Lycium ruthenicum (LR) and Lycium barbarum (LB)
plant extracts to be used in the following experiments, we first assessed the toxicity of different
concentrations of these plant extracts in wild-type (WT) worms. For this, the profile of bacterial
food consumption by Lycium -treated animals was measured daily and used as proxy of worm
development and well-being (RAW data in Dataset R1 [6] ). None of the Lycium plant extracts
concentrations tested (0.25 to 1 mg/mL) led to differences in food consumption measured by
OD595 nm when compared to the non-toxic control DMSO 1% ( Fig. 1 , Table S1 (Appendix A)). In
the case of Hyptis suaveolens (HS), Hyptis pectinata (HP) and Hyptis marrubioides (HM) extracts,
OD595 nm measures in treatment conditions were also similar to the non-toxic control [1] . 
1.2. Effect of plant extracts treatment on the speed of the C. elegans model of tauopathy, during 
spontaneous and stimulated movement 
In a transgenic C. elegans model of the human tauopathy Frontotemporal dementia and
parkinsonism linked to chromosome 17 (FTDP-17), that expresses pan-neuronally a full-length
mutant Tau V337M [4] , the chronic treatment with HS, HP and HM plant extracts increased sig-
nificantly the stimulated speed of worms, at the highest concentrations, when compared with
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Fig. 1. Consumption of bacterial food by WT C. elegans treated with distinct concentrations of Lycium ruthenicum (LR) 
and Lycium barbarum (LB) (0.25-1 mg/mL). Animals were also treated with DMSO 1% (non-toxic treatment) and DMSO 
5% (toxic treatment). Bacterial consumption was estimated through optical density (OD) measurement at 595 nm for 7 
days. Graphs are representative of one independent assessment with at least three technical replicates being considered 





























c  he DMSO treatment: at 0.5 and 1 mg/mL for HS and HP, and at 0.1 and 0.5 mg/mL for HM
 Fig. 2 , Table S2 (Appendix A) and Dataset R2 [6] ). However, the treatment of the same model
ith LB and LR plant extracts did not change velocity in comparison with the control condition.
 Fig. 2 , Table S2 (Appendix A) and Dataset R2 [6] ). 
Similarly, when the animals’ speed was evaluated during their spontaneous movement, ve-
ocity was higher for HS, HP and HM treatment [1] , and no major effect in speed was seen
pon treatment with LB and LR plant extracts ( Fig. 3 , Table S3 (Appendix A) and Dataset R2 [6] ).
f note, treatment with the distinct extracts did not alter the overall development/size of the
ransgenic C. elegans model of Tauopathy (Table S2 and S3 (Appendix A), Dataset R3 [6] ). 
.3. Effect of plant extracts treatment on the speed of the C. elegans model of MJD, during 
pontaneous and stimulated movement 
The effect of plant extracts treatment was also tested in a C. elegans model of Machado-
oseph disease (MJD), previously generated and characterized in our laboratory, which expresses
an-neuronally a mutant version of human ATXN3 (mATXN3) and exhibits locomotion defects
s a key hallmark of the disease [5] . 
In that case, none of the plant extracts was able to improve animals speed, when the move-
ent was stimulated by tapping the Petri dish ( Fig. 4 , Table S4 (Appendix A) and Dataset R4
6] ). When evaluated in spontaneous movement, Hyptis -treated worms presented significantly
ncreased velocity, when compared with the DMSO control condition [1] , however, LB and LR
reatments were unable to change animals’ velocity ( Fig. 5 , Table S5 (Appendix A) and Dataset
4 [6] ). 
Also, in this case, the body length of the C. elegans model of MJD, treated with the distinct
xtracts, was comparable to the DMSO treatment (Table S4 and S5 (Appendix A), Dataset R5 [6] ).
.4. Oxidative stress resistance of the C. elegans models of neurodegenerative diseases treated with 
yptis spp. and Lycium spp. plant extracts 
The C. elegans models of neurodegenerative diseases, pre-treated with 1 mg/mL of each ex-
ract, were submitted to an oxidative insult triggered by juglone (240 μM). The treatment with
yptis spp. extracts led to increased oxidative stress resistance in both disease models [1] . Con-
erning the treatment with LR and LB extracts, only the model of tauopathy presented increased
D. Vilasboas-Campos, M.D. Costa and A. Teixeira-Castro et al. / Data in Brief 33 (2020) 106598 5 
Fig. 2. Mean velocity of mTau animals treated with different concentrations of plant extracts, when their movement 
was stimulated by “tapping”. Each bar represents means ± SEM of 3-9 experiments with at least 50 worms analysed 
in each assay per condition. p ≤ 0.05 ( ∗), p ≤ 0.01 ( ∗∗) and p ≤ 0.001 ( ∗∗∗), One-way ANOVA followed by the bilateral 
Dunnet test (post hoc). 
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Fig. 3. Mean spontaneous speed of mTau animals treated with different concentrations of LB and LR plant extracts. Each 
bar represents means ± SEM of 9 experiments with at least 50 worms analysed in each assay per condition. p ≤ 0.05 






















l  urvival percentage upon juglone exposure when chronically treated with the LR extract ( Fig. 6 ,
able S6 (Appendix A), Datasets R6 and R7 [6] ). 
. Experimental Design, Materials and Methods 
.1. Plant extracts 
Leaves of Hyptis suaveolens, Hyptis pectinata and Hyptis marrubioides plants were collected in
he region of Rio Verde (Goiás, Brazil) and fruits of Lycium barbarum and Lycium ruthenicum were
ollected in China. Extracts were prepared as described in [1] . Briefly, biomass was lyophilized
nd extracted with methanol 80%, in the dark, for 5 days. After this, solutions were filtered,
vaporated in a rotavapor (in the dark, at 40 °C), lyophilized to obtain a powder and stored at
20 °C. For the in vivo tests, the plant extracts powder was dissolved in DMSO 100% and stored
s a stock concentration of 100 mg/mL at 4 °C, protected from light. 
.2. C. elegans strains, maintenance and synchronization 
The C. elegans model of MJD was previously generated by our research team [5] , the C. elegans
odel of FTDP-17 was kindly provided by Dr. Brian Kraemer and wild-type strain (N2; Bristol
train) was obtained from CGC. 
Animals were grown at 20 °C on nematode growth medium (NGM) agar plates seeded with
. coli strain OP50. The synchronization of C. elegans was achieved by hypochlorite treatment
 ∼2.6% NaClO and 0.5 M NaOH) for 5 min. 
.3. Toxicity assessment 
The extracts toxicity was evaluated in the C. elegans wild-type Bristol strain N2 as exempli-
ed in the experimental design in Fig. 7 , in Section 2 . A food-clearance assay was performed in
iquid culture using 96-well plates, as already described [7] . Each well contained a final volume
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Fig. 4. Mean stimulated velocity of mATXN3 animals treated with different concentrations of plant extracts. Each bar 
represents means ± SEM of 3-9 experiments with at least 50 worms analysed in each assay per condition. p ≤ 0.05 ( ∗), 
p ≤ 0.01 ( ∗∗) and p ≤ 0.001 ( ∗∗∗), One-way ANOVA followed by the bilateral Dunnet test (post hoc). 
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Fig. 5. Mean spontaneous velocity of mATXN3 animals treated with different concentrations of plant extracts. Each bar 
represents means ± SEM of 9 experiments with at least 50 worms analysed in each assay per condition. p ≤ 0.05 ( ∗), p 
≤ 0.01 ( ∗∗) and p ≤ 0.001 ( ∗∗∗), One-way ANOVA followed by the bilateral Dunnet test (post hoc). 
Fig. 6. Effect of Lycium spp. extracts treatment (at 1mg/mL) on the oxidative stress resistance of the C. elegans models 
of MJD and Tauopathy. Oxidative stress was induced by exposure to 240 μM of juglone, for 1 hour. Data on the graph 
are represented as mean survival percentages ± SEM from 5 independent experiments. (N = ∼10 0 0 animals). p ≤ 0.05 







f 60 μL, comprising 15 μL of eggs suspension (20–25 eggs), 20 μL of E. coli strain OP50 bacteria
previously inactivated by cycles of freeze/thawing, with OD 595 nm of 0.6–0.7) and 25 μL of
ach plant extract (at different concentrations) or DMSO 1% and 5% (non-toxic and toxic treat-
ents, respectively). Worms were grown with continuous shaking at 180 rpm at 20 °C (Shell Lab
ncubator shaker). The consumption of the E. coli strain OP50 was measured daily for 7 days at
95 nm (NanoQuant Plate TM -Tecan). 
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Fig. 7. Schematic representation of the experimental workflow used to evaluate the impact of plant extracts treatment 
in C. elegans models of neurodegenerative diseases: 1) toxicity of the plant extracts in WT strain 2) oxidative stress 
resistance (after juglone insult) and 3) evaluation of motor function (animals’ spontaneous/stimulated speed), in the 






2.4. Motor phenotype 
2.4.1. Chronic treatment of the C. elegans with plant extracts 
The chronic treatment of C. elegans with plant extracts (from L1 to day 4 after hatching) was
performed in liquid culture using 96-well-plates. The treatment plates comprised per well: 45-
50 L1 animals; plant extracts at the respective concentrations and DMSO 1% as control; and E.
coli strain OP50 inactivated bacteria resuspended in S-medium complete to a final OD 595 nm of
0.8-0.9. The plates were incubated at 20 °C with shaking at 180 rpm (Shell lab incubator shaker).








































.4.2. Motor behavior assays in the C. elegans disease models 
The motor phenotype of the MJD and Tauopathy C. elegans models was evaluated after treat-
ent with the plant extracts as exemplified in the experimental design in Fig. 7 , in Section 2 .
t day 4 after hatching, the animals were removed from the liquid medium to unseeded NGM
lates, for 30 minutes. A population of animals in the NGM plate was recorded using an Olym-
us SZX7 stereomicroscope with an integrated camera (Olympus SC30), for 1 minute while
oving spontaneously (in each trial and for each condition two videos were recorded) or for
0 seconds while moving after stimulated by a mechanic stimulus (plate tap). To ensure that
he movement stimulus was similar throughout the procedure, the plates were dropped from a
eight of 8 cm, three consecutive times, before being placed in the stage plate. In that case, in
ach trial and for each condition one video was recorded. The videos were processed using the
mage J® software [2] and the Wrmtrck plugin [3] . 
.5. Resistance to juglone-induced oxidative stress 
Transgenic C. elegans models of MJD and FTDP-17, chronically treated with plant extracts un-
il day 4 after hatching, were washed three times in M9 buffer before incubation with a ROS
enerator, 5-Hydroxy-1,4-naphthoquinone (Sigma-Aldrich, St. Louis, MO), also known as juglone.
pproximately 250-300 animals were incubated with 240 μM Juglone, for 1 hour at 20 °C, in
iquid medium (12-well plate), with continuous agitation as exemplified in the experimental
esign in Fig. 7 , in Section 2 . After oxidative stress, animals were washed with M9 buffer 5
imes and moved to fresh NGM plates seeded with E. coli strain OP50 for a recovery period of
6 hours, when the survival percentage was determined by touch-provoked movement. Animals
ere scored as dead when they failed to respond after touching with a platinum wire pick. 
.6. Statistical analysis 
Statistical analysis was performed using IBM® SPSS® Statistics software (version 23.0). Con-
inuous variables were tested for normal distribution (Shapiro–Wilk or Kolmogorov–Smirnov
ormality test), for homogeneity of variance (Levene’s test) and outliers. Data were analyzed
sing One-Way Anova, Dunnett’s multiple comparison analysis for post hoc comparison. All ex-
eriments were run at least in triplicate (n ≥ 3) and data presented correspond to mean ± SEM
ith significance levels of p ≤ 0.05 ( ∗), p ≤ 0.01 ( ∗∗) and p ≤ 0.001 ( ∗∗∗), respectively. 
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